Stay updated on RO6874281 for HER2-positive Cancer: Clinical Trial

Sign up to get notified when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RO6874281 for HER2-positive Cancer: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s displayed application/site revision version was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:56:37.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; removed revision: v3.5.0 from the history.
    Difference
    0.0%
    Check dated 2026-04-17T02:32:44.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    A new revision (v3.5.0) was added to the record history, and the prior revision (v3.4.3) was removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:16:13.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the page history.
    Difference
    0.0%
    Check dated 2026-03-11T23:57:13.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now listed; the funding-status notice and the older Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:53.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Introduced a site-wide notice about government funding and operation status. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:20:34.000Z thumbnail image

Stay in the know with updates to RO6874281 for HER2-positive Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.